Hunter Haines is a trusted adviser to entrepreneurs, venture capitalists and emerging growth companies. He represents startup and mature private and public companies and investors across a broad range of industries, including fintech, biotechnology, pharmaceutical, life sciences, consumer goods, retail and financial services.

As an associate in the firm’s practice group for startup and emerging growth companies, NEXT powered by Shulman Rogers, Hunter advises clients in a wide array of matters, including public and private offerings, venture capital transactions, securities law compliance, corporate governance, executive and employee compensation, commercial contracts, business planning and exit strategies. In addition to his startup and emerging growth company practice, Hunter’s active mergers and acquisition practice allows him to advise his clients throughout the life cycle of their business from formation to exit.

Clients appreciate Hunter’s perspective, his diligence and the care he shows for their overall business objectives. He approaches each matter with no preconceived notions, and takes the time to listen to and understand the client’s specific needs and business goals.

“Since our company is headquartered in London, it was imperative that we understood all of the legalities doing business in the US and Hunter made us feel confident that we did.”    

–Nelson Jones, CEO of Kula Technology Labs, Inc. YC W22

Hunter received a B.S. from Towson University, and a J.D. and Business Law Certificate from the University of Maryland, Francis King Carey School of Law. During law school, Hunter served as an Asper Fellow for the Honorable Robert N. McDonald of Maryland Court of Appeals and as a judicial intern for the Honorable George L. Russell, III of the United States District Court, District of Maryland. He was published in, and served as a Notes and Comments Editor for, the Maryland Law Review.

Professional & Community Affiliations
Ones to Watch Award 2024

Results

Issuer Representation (among others):

  • $25.0 million Series B Preferred Stock financing for New York-based real estate technology company
  • $9.0 million Series A Preferred Stock financing for Maryland-based technology company
  • $5.0 million Series Seed Preferred Stock financing for Maryland-based biotech company
  • $5.0 million Series AA Preferred Stock financing for Maryland-based biotech company
  • $4.0 million Simple Agreement for Future Equity financing for an entertainment technology company
  • $4.5 million Series Seed Preferred Stock Financing for U.K.-based fintech company
  • $3.0 million Series Seed Preferred Stock Financing for Virginia-based fintech company
  • $2.5 million Preferred Unit financing for Texas-based entertainment company
  • $2.5 million Convertible Note financing for a Maryland Benefit Corporation
  • $2.0 million Series Seed Preferred Stock financing for Maryland-based biotech company
  • $2.0 million Common Stock Financing for a New York-based biotechnology company
  • $1.5 million Simple Agreement for Future Equity for New York-based real estate technology company
  • $1.0 million Common Stock Financing for a New York-based biotechnology company
  • $2.5 million Convertible Note financing for a Maryland Benefit Corporation
  • $1.070 million Crowdfund financing for New York-based urban development company
  • $1.0 million Simple Agreement for Future Equity for U.K.-based Y-Combinator Alumni
  • $900,000 Simple Agreement for Future Equity for U.S.-based technology company
  • $850,000 Convertible Note financing for Maryland-based technology company
  • $750,000 Simple Agreement for Future Equity for Pennsylvania-based technology company
  • $500,000 Convertible Note financing for Maryland-based consumer health company
  • $500,000 Simple Agreement for Future Equity financing for Virginia-based government contracting company
  • $500,000 Simple Agreement for Future Equity financing for Washington, D.C.-based consumer goods company
  • $500,000 Simple Agreement for Future Equity financing for California-based health technology company
  • $250,000 Common Stock Financing for Maryland-based consumer goods company
  • $250,000 Convertible Note financing for Maryland-based retail company
  • $250,000 Common Stock Financing for a New York-based biotechnology company

Maryland State Financing Representation:

  • Represented issuer of a $250,000 convertible note under the Maryland Momentum Fund, formed and administered by the University System of Maryland (“USM”)
  • Represented issuer of a $100,000 convertible note under the Maryland Momentum Fund, formed and administered by USM
  • Represented issuer of a $200,000 convertible note under the Builder Fund, formed and administered by Maryland’s Technology Development Corporation (“TEDCO”)
  • Represented issuer of a $100,000 convertible note under the Builder Fund, formed and administered by TEDCO

Investor Representation (among others):

  • $25.0 million Series B Preferred Stock financing Investment for Ohio-based venture capital fund
  • $2.0 million Series A-2 Preferred Stock financing Investment for Virginia area syndicated fund
  • Numerous <$1M Convertible Note and Simple Agreement for Future Equity investments across various industries

M/A Transactions (among others):

  • Deal team of $292.5 million sell-side acquisition of biotechnology company
  • $35 million buy-side acquisition of a minority interest in global consumer goods company
  • $10 million sell-side acquihire of technology company
  • $4.5 million sell-side acquisition of global lobbying firm
  • $1 million sell-side acquisition of biotechnology company

Recognition

  • Best Lawyers Ones to Watch, 2024

Publications